B
Bernstein Latest Price Targets & Analyst Ratings
| Stock | Analyst | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|---|
|
SARO
126
StandardAero, Inc.
SARO
$8.88B
|
DH
Douglas Harned
| $26.55 | $39 |
47%
upside
| Outperform | 10 months ago |
|
127
DexCom
DXCM
$31.6B
|
LH
Lee Hambright
| $80.51 | $86 |
7%
upside
| Outperform | 10 months ago |
|
128
Confluent
CFLT
$6.67B
|
PW
Peter Weed
| $19.34 | $33 |
71%
upside
| Outperform | 10 months ago |
|
129
General Motors
GM
$55.5B
|
AY
Adrian Yanoshik
| $58.27 | $55 |
6%
downside
| Market Perform | 10 months ago |
|
130
General Dynamics
GD
$86.8B
|
DH
Douglas Harter
| $322.86 | $331 |
3%
upside
| Market Perform | 10 months ago |
|
131
ServiceNow
NOW
$190B
|
PW
Peter Weed
| $913.80 | $913 |
0%
downside
| Outperform | 10 months ago |
|
132
Boston Scientific
BSX
$159B
|
LH
Lee Hambright
| $107.22 | $100 |
7%
downside
| Outperform | 10 months ago |
|
133
Thermo Fisher Scientific
TMO
$186B
|
EB
Eve Burstein
| $492.60 | $620 |
26%
upside
| Market Perform | 10 months ago |
|
134
Global Payments
GPN
$21.3B
|
HR
Harshita Rawat
| $87.78 | $112 |
28%
upside
| Market Perform | 10 months ago |
|
135
Dollar Tree
DLTR
$20.6B
|
BF
Brandon Fletcher
| $101.12 | $76 |
25%
downside
| Market Perform | 10 months ago |
|
136
Target
TGT
$42.3B
|
DR
Dean Rosenblum
| $93.17 | $168 |
80%
upside
| Market Perform | 10 months ago |
|
137
Dollar General
DG
$24.1B
|
BF
Brandon Fletcher
| $109.28 | $98 |
10%
downside
| Outperform | 10 months ago |
|
138
Costco
COST
$427B
|
DR
Dean Rosenblum
| $963.48 | $1,016 |
5%
upside
| Outperform | 10 months ago |
|
139
Howmet Aerospace
HWM
$71.8B
| $178.20 | $127 |
29%
downside
| Outperform | 10 months ago |
|
|
140
Datadog
DDOG
$47.5B
|
PW
Peter Weed
| $136.08 | $151 |
11%
upside
| Outperform | 10 months ago |
|
141
APA Corp
APA
$8.14B
|
BB
Bob Brackett
| $22.75 | $28 |
23%
upside
| Market Perform | 10 months ago |
|
142
United Airlines
UAL
$34.5B
|
DV
David Vernon
| $106.59 | $85 |
20%
downside
| Outperform | 10 months ago |
|
143
Abbott
ABT
$231B
|
LH
Lee Hambright
| $132.94 | $138 |
4%
upside
| Outperform | 10 months ago |
|
144
Moderna
MRNA
$9.78B
|
CB
Courtney Breen
| $25.14 | $55 |
119%
upside
| Market Perform | 10 months ago |
|
145
Bristol-Myers Squibb
BMY
$96B
| $47.14 | $56 |
19%
upside
| Market Perform | 10 months ago |
|
|
146
Merck
MRK
$212B
| $84.71 | $115 |
36%
upside
| Market Perform | 10 months ago |
|
|
147
Eli Lilly
LLY
$652B
| $727.21 | $1,100 |
51%
upside
| Outperform | 10 months ago |
|
|
148
Pfizer
PFE
$141B
|
CB
Courtney Breen
| $24.88 | $32 |
29%
upside
| Market Perform | 10 months ago |
|
149
Gilead Sciences
GILD
$143B
|
AG
Aaron Gal
| $115.05 | $105 |
9%
downside
| Outperform | 10 months ago |
|
150
AbbVie
ABBV
$375B
|
AG
Aaron Gal
| $212.56 | $203 |
5%
downside
| Market Perform | 10 months ago |
|